11 As at Mar 31, 2020 As at Dec 31, 2019 Change MB % MB % MB % Provision for Employee Benefit 552.17 2.82 551.45 2.93 0.73 0.13 Lease Liabilities 358.49 1.83 - - 358.49 100.00 Deferred Rental Income
following details. Financial performance Statement of income Consolidated financial statements for the year 2018 2017 Change (Audited) (Audited/Restated) Increase (Decrease) THB Million % THB Million % THB
Balance by Quarter Change Topic Q1-23 Q4-22 Q1-22 Q1-23 VS Q4-22 Q1-23 VS Q1-22 (Million Baht: MB) (MB) % (MB) % Total revenue 1,296.7 1,729.1 1,399.2 (432.4) (25.0) (102.5) (7.3) Total operating expenses
observed a growth in subsidiary business especially in distress debt management and mobile phone distributor. The details of the Company’s performance are explained as follows: 2016 2017 Change MB % MB % MB
Performance for the Second Quarter of 2018 (Unit: Million Baht) Q2-2018 Q1-2018 Change Q2-2017 Change Million Baht Percent Million Baht Percent Net Interest Income 24,367 23,696 671 2.83 23,343 1,024 4.38 Non
- 2019 Balance by Quarter Change Q3–19 Q2–19 Q3–18 Q3–19 VS Q2–19 Q3–19 VS Q3–18 (Million Baht: MB) (MB) % (MB) % Total Revenue 1,799.1 1,730.1 1,053.3 69.0 4.0 745.8 70.8 Total Operating Expenses 1,677.5
of March 31, 2024, which can be summarized as follows: 1) Profit & Loss Analysis : Q1 2024 (3 Months) (Unit : Million Baht unless otherwise stated) Q1 2024 Q1 2023 Change Amount % Change Total Revenues
other income. Net profit margin was at 4.2% . Revenues The structure of revenues for the year ended 31 December 2019 and 2018 are as follows; Unit: THB million Y2019 Y2018 % Change 1. Revenue from sales
venture, financial costs and income tax expenses 5.93 3.54 2.39 67.25 6.12 3.55 2.57 72.53 Share of profit from investment in joint venture 0.90 (1.49) 2.39 160.55 - - - N/A Profit before financial costs
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.158/2018 12 November 2018 Subject : Explanation of the change in operating results of Q3/2018 which